Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.81)
# 1,940
Out of 5,033 analysts
26
Total ratings
62.5%
Success rate
18.82%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $432.69 | -20.50% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $18.00 | +197.30% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $35.12 | +13.90% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $24.44 | +22.75% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $5.10 | +66.67% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $15.80 | +1.27% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.55 | +41,900.00% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $2.44 | +18,752.46% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $2.93 | +1,640.61% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $16.22 | -1.36% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $5.56 | +709.35% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $432.69
Upside: -20.50%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $18.00
Upside: +197.30%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $35.12
Upside: +13.90%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $24.44
Upside: +22.75%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $5.10
Upside: +66.67%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $15.80
Upside: +1.27%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.55
Upside: +41,900.00%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $2.44
Upside: +18,752.46%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $2.93
Upside: +1,640.61%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $16.22
Upside: -1.36%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $5.56
Upside: +709.35%